- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 47/26 - Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharidesDerivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
Patent holdings for IPC class A61K 47/26
Total number of patents in this class: 11030
10-year publication summary
|
808
|
833
|
968
|
1031
|
1204
|
1142
|
1113
|
1170
|
1125
|
879
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Regeneron Pharmaceuticals, Inc. | 4790 |
102 |
| Amgen Inc. | 4436 |
83 |
| Azurity Pharmaceuticals, Inc. | 263 |
79 |
| Takeda Pharmaceutical Company Limited | 2699 |
75 |
| Genentech, Inc. | 4119 |
68 |
| Novartis AG | 10175 |
62 |
| Allergan, Inc. | 2155 |
54 |
| Merck Sharp & Dohme LLC | 3738 |
52 |
| Pfizer Inc. | 3413 |
50 |
| Janssen Biotech, Inc. | 1785 |
50 |
| Hoffmann-La Roche Inc. | 3825 |
49 |
| Chiesi Farmaceutici S.p.A. | 952 |
47 |
| Daiichi Sankyo Company, Limited | 1891 |
45 |
| Chugai Seiyaku Kabushiki Kaisha | 1422 |
42 |
| Alkermes Pharma Ireland Limited | 255 |
40 |
| Hanmi Pharm. Co., Ltd. | 602 |
39 |
| F. Hoffmann-La Roche AG | 7800 |
38 |
| Bristol-myers Squibb Company | 4764 |
35 |
| Astellas Pharma Inc. | 1040 |
35 |
| Arecor Limited | 105 |
32 |
| Other owners | 9953 |